NHS agrees to fund 'vital' MS drug Daily Mail Wed, 22 Aug 2007 0:24 AM PDT An MS drug that cuts the chance of relapse by nearly three-quarters is to be made available on the NHS. Around 3,000 patients with the most severe form of multiple sclerosis could benefit from the decision by the Government's 'rationing' body.

UK health authority recommends Tysabri Ireland Business World Tue, 21 Aug 2007 11:56 PM PDT Elan's Tysabri has been recommended for use in people with highly active relapsing remitting multiple sclerosis (RRMS) by the UK's National Institute for Health and Clinical Excellence (NICE).